Point72 Europe (London) LLP Catalyst Biosciences, Inc. Transaction History

Point72 Europe (London) LLP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $780,725 - $1.04 Million	-83,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $760,685 - $2.41 Million	83,500 New	83,500 $974,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Point72 Europe (London) LLP, based on Form 13F filings with the SEC.

Stay updated on Point72 Europe (London) LLP with notifications on news.